La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

MedAvail Holdings Bilan de santé

Santé financière contrôle des critères 3/6

MedAvail Holdings possède un total de capitaux propres de $23.0M et une dette totale de $1.5M, ce qui porte son ratio d'endettement à 6.5%. Son actif total et son passif total sont $29.9M et de $6.9M.

Informations clés

6.5%

Ratio d'endettement

US$1.51m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	US$14.36m
Fonds propres	US$23.05m
Total du passif	US$6.86m
Total des actifs	US$29.91m

Mises à jour récentes de la santé financière

Recent updates

Slammed 31% MedAvail Holdings, Inc. (NASDAQ:MDVL) Screens Well Here But There Might Be A Catch

Aug 17

Is There An Opportunity With MedAvail Holdings, Inc's (NASDAQ:MDVL) 32% Undervaluation?

Feb 20

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de MDVL ( $27.0M ) dépassent ses passifs à court terme ( $4.2M ).

Passif à long terme: Les actifs à court terme de MDVL ( $27.0M ) dépassent ses passifs à long terme ( $2.7M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: MDVL dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Données insuffisantes pour déterminer si le ratio d'endettement de MDVL a diminué au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: MDVL dispose de moins d'un an de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: MDVL dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 24.4 % chaque année

MedAvail Holdings Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Nasdaq to Delist Common Stock of MedAvail Holdings

MedAvail Holdings, Inc. Filed for Bankruptcy

MedAvail Holdings, Inc. announced delayed 10-Q filing

MedAvail Announces 1-for-50 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

MedAvail Holdings, Inc. announced delayed 10-Q filing

MedAvail Holdings Receives A Letter from Nasdaq Regarding Minimum Bid Price Requirement

Recent updates

MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from S&P TMI Index

MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from NASDAQ Composite Index

Nasdaq to Delist Common Stock of MedAvail Holdings

MedAvail Holdings, Inc. Filed for Bankruptcy

MedAvail Holdings, Inc. Announces Board of Directors Resignations

MedAvail Holdings, Inc. announced delayed 10-Q filing

Slammed 31% MedAvail Holdings, Inc. (NASDAQ:MDVL) Screens Well Here But There Might Be A Catch

High number of new and inexperienced directors

MedAvail Announces 1-for-50 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

MedAvail Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2023

MedAvail Holdings, Inc. announced delayed 10-Q filing

Full year 2022 earnings: EPS exceeds analyst expectations

High number of new and inexperienced directors

Medavail Holdings, Inc. Announces Executive Resignations

German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Holiday CVS, L.L.C., Longs Drug Stores California, Inc. and Woodward Detroit CVS, L.L.C. entered into the asset purchase and sale agreement to acquire Pharmacy Assets of MedAvail Holdings, Inc. for $4.4 million.

Medavail Holdings, Inc. Initiates Reduction in Force

High number of new and inexperienced directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

MedAvail Holdings, Inc. Provides Revenue Guidance for the Full Year 2022

MedAvail Holdings Receives A Letter from Nasdaq Regarding Minimum Bid Price Requirement

MedAvail Holdings, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Consensus estimates of losses per share improve by 31%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

MedAvail Holdings, Inc. Provides Revenue Guidance for the Full Year 2022

MedAvail Holdings: More Stock Dilution Seems Inevitable And I'm Bearish

MedAvail Holdings, Inc. to Report Q2, 2022 Results on Aug 11, 2022

MedAvail Holdings, Inc.(NasdaqCM:MDVL) dropped from Russell 2000 Growth Index

Consensus forecasts updated

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

MedAvail Holdings, Inc., Annual General Meeting, Jun 14, 2022

Price target decreased to US$5.00

Less than half of directors are independent

Consensus estimates of losses per share improve by 22%

Price target increased to US$8.00

MedAvail Holdings, Inc announced that it expects to receive $50.04375 million in funding

Medavail Holdings, Inc Strengthens Leadership Team

MedAvail Holdings, Inc Provides Revenue Guidance for the Fourth Quarter and Full Year 2021

Price target decreased to US$7.50

Third quarter 2021 earnings released: US$0.34 loss per share (vs US$0.74 loss in 3Q 2020)

Consensus revenue estimates fall to US$21.1m

Some Analysts Just Cut Their MedAvail Holdings, Inc (NASDAQ:MDVL) Estimates

Second quarter 2021 earnings released: US$0.32 loss per share (vs US$4.11 loss in 2Q 2020)

Medavail Holdings, Inc Revises Revenue Guidance for the Full Year 2021

Calculating The Intrinsic Value Of MedAvail Holdings, Inc (NASDAQ:MDVL)

MedAvail Holdings, Inc Narrows Revenue Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released: US$0.84 loss per share (vs US$16.85 loss in FY 2019)

MedAvail Holdings, Inc to Report Q4, 2020 Results on Mar 30, 2021

Is There An Opportunity With MedAvail Holdings, Inc's (NASDAQ:MDVL) 32% Undervaluation?

MedAvail’s SpotRx Pharmacy and Cigna Medical Group Partner to Help Improve Medication Access in Phoenix

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines